BPG is committed to discovery and dissemination of knowledge
Retrospective Study
©The Author(s) 2015.
World J Gastroenterol. Sep 21, 2015; 21(35): 10166-10173
Published online Sep 21, 2015. doi: 10.3748/wjg.v21.i35.10166
Table 1 Clinical symptoms, laboratory findings, and computed tomography findings
XGC(n = 6)GB carcinoma (n = 16)P value
Age (mean ± SD, yr)64.3 ± 9.767.9 ± 12.00.5148
Gender0.8558
Male48
Female28
Abdominal pain0.4806
Presence48
Absence28
Fever0.4726
Yes11
No515
Jaundice0.6707
Yes14
No512
Albumin (mean ± SD, mg/dL)3.8 ± 0.43.8 ± 0.30.8090
Neutrophil/lymphocyte ratio (mean ± SD)2.1 ± 0.92.4 ± 1.00.6280
CEA (mean ± SD)1.9 ± 0.63.1 ± 3.50.2205
CA19-9 (mean ± SD)232.7 ± 488.5354.0 ± 737.10.6806
Cholecystolithiasis0.0116
Yes54
No112
Diffuse gallbladder wall thickening (CT findings)0.1551
Yes33
No313
Continuous mucosal line (CT findings)0.0616
Yes32
No314
Intramural hypoattenuated nodule0.0024
Yes31
No315
Bile duct dilatation0.9035
Yes13
No513


Write to the Help Desk